Because the level of SENP3 in macrophages appeared to be comparable to that in tumor cells (Fig. 6A), these results collectively suggest that SENP3 level in macrophages, as well as in the whole breast cancer tissues, could serve as a biomarker for breast cancer progression and prognosis of breast cancer patients. This evidence concerns the gene SENP3 and breast cancer.